Physician profile
Colin Patrick Bird
NPI 1497950927
$39,029.40
in general payments reported to CMS, 2019-2025
12 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,456 · 2021: $7,313 · 2022: $5,033 · 2023: $3,310 · 2024: $16.97 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,128 · Travel and Lodging: $907 · Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,128.00 |
| Travel and Lodging | $907.37 |
| Food and Beverage | $530.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,732.01 | 2019-2025 | |
| Thd America, INC. | $13,258.03 | 2019-2025 | |
| Medical Device Business Services, INC. | $865.18 | 2019 | |
| Medtronic USA, INC. | $228.50 | 2019-2020 | |
| Axonics, INC. | $185.45 | 2022-2024 | Axonics |
| Ethicon US, LLC | $153.60 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $146.95 | 2022-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Boston Scientific Corporation | $134.02 | 2025 | Axonics |
| Medtronic, INC. | $123.19 | 2025 | Interstim, Altaviva |
| Stryker Corporation | $110.05 | 2019 | |
| Applied Medical Resources Corporation | $67.19 | 2019 | |
| Galvanize Therapeutics, INC | $25.23 | 2025 | Aliya System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.